Lefradafibanum
Lefradafibanum Uses, Dosage, Side Effects, Food Interaction and all others data.
Lefradafibanum is an oral platelet glycoprotein IIb/IIIa receptor antagonist being investigated in the treatment of angina.
Lefradafibanum, an orally active prodrug of fradafiban, is a novel glycoprotein (IIb/IIIa) inhibitor for the treatment of unstable angina. Development was discontinued in 2000 due to lack of efficacy.
Trade Name | Lefradafibanum |
Generic | Lefradafiban |
Lefradafiban Other Names | Lefradafibán, Lefradafiban, Léfradafiban, Lefradafibanum |
Type | |
Formula | C23H25N3O6 |
Weight | Average: 439.4611 Monoisotopic: 439.174335547 |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | September 19, 2023 at 7:00 am |
Uses
For the treatment of unstable angina.
How Lefradafibanum works
GPIIb/IIIa inhibitors, such as lefradafiban, block the final common pathway of platelet aggregation.
Innovators Monograph
You find simplified version here Lefradafibanum